Basigin Mediates Pulmonary Hypertension by Promoting Inflammation and Vascular Smooth Muscle Cell Proliferation

被引:83
|
作者
Satoh, Kimio [1 ]
Satoh, Taijyu [1 ]
Kikuchi, Nobuhiro [1 ]
Omura, Junichi [1 ]
Kurosawa, Ryo [1 ]
Suzuki, Kota [1 ]
Sugimura, Koichiro [1 ]
Aoki, Tatsuo [1 ]
Nochioka, Kotaro [1 ]
Tatebe, Shunsuke [1 ]
Miyamichi-Yamamoto, Saori [1 ]
Miura, Masanobu [1 ]
Shimizu, Toru [1 ]
Ikeda, Shohei [1 ]
Yaoita, Nobuhiro [1 ]
Fukumoto, Yoshihiro [1 ]
Minami, Tatsuro [1 ]
Miyata, Satoshi [1 ]
Nakamura, Kazufumi [2 ]
Ito, Hiroshi [2 ]
Kadomatsu, Kenji [3 ]
Shimokawa, Hiroaki [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan
[2] Okayama Univ, Grad Sch Med, Dept Cardiovasc Med, Okayama 7008530, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan
关键词
anoxia; hypertension; pulmonary; inflammation; muscle; smooth; vascular; oxidative stress; pulmonary circulation; ENDOGENOUS ERYTHROPOIETIN SYSTEM; RHO-KINASE INHIBITOR; ARTERIAL-HYPERTENSION; CYCLOPHILIN-A; OXIDATIVE STRESS; IMMUNOGLOBULIN SUPERFAMILY; THERAPEUTIC TARGET; HEME OXYGENASE-1; NUCLEAR FACTOR; UP-REGULATION;
D O I
10.1161/CIRCRESAHA.115.304563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Cyclophilin A (CyPA) is secreted from vascular smooth muscle cells (VSMCs) by oxidative stress and promotes VSMC proliferation. However, the role of extracellular CyPA and its receptor Basigin (Bsg, encoded by Bsg) in the pathogenesis of pulmonary hypertension (PH) remains to be elucidated. Objective: To determine the role of CyPA/Bsg signaling in the development of PH. Methods and Results: In the pulmonary arteries of patients with PH, immunostaining revealed strong expression of CyPA and Bsg. The pulmonary arteries of CyPA(+/-) and Bsg(+/-) mice exposed to normoxia did not differ in morphology compared with their littermate controls. In contrast, CyPA(+/-) and Bsg(+/-) mice exposed to hypoxia for 4 weeks revealed significantly reduced right ventricular systolic pressure, pulmonary artery remodeling, and right ventricular hypertrophy compared with their littermate controls. These features were unaltered by bone marrow reconstitution. To further evaluate the role of vascular Bsg, we harvested pulmonary VSMCs from Bsg(+/+) and Bsg(+/-) mice. Proliferation was significantly reduced in Bsg(+/-) compared with Bsg(+/+) VSMCs. Mechanistic studies demonstrated that Bsg(+/-) VSMCs revealed reduced extracellular signal-regulated kinase 1/2 activation and less secretion of cytokines/chemokines and growth factors (eg, platelet-derived growth factor-BB). Finally, in the clinical study, plasma CyPA levels in patients with PH were increased in accordance with the severity of pulmonary vascular resistance. Furthermore, event-free curve revealed that high plasma CyPA levels predicted poor outcome in patients with PH. Conclusions: These results indicate the crucial role of extracellular CyPA and vascular Bsg in the pathogenesis of PH.
引用
收藏
页码:738 / +
页数:31
相关论文
共 50 条
  • [21] Selenoprotein p promotes vascular smooth muscle cell proliferation and pulmonary hypertension - a possible novel therapeutic target
    Kikuchi, N.
    Satoh, K.
    Omura, J.
    Satoh, T.
    Kurosawa, R.
    Nogi, M.
    Tatebe, S.
    Aoki, T.
    Sugimura, K.
    Shimokawa, H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1206 - 1206
  • [22] Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells
    Jin, Haifeng
    Wang, Yueyue
    Zhou, Lei
    Liu, Lu
    Zhang, Peng
    Deng, Wuguo
    Yuan, Yuhui
    JOURNAL OF PINEAL RESEARCH, 2014, 57 (04) : 442 - 450
  • [23] Hippo-Integrin Linked Kinase Crosstalk Regulates Pulmonary Vascular Smooth Muscle Cell Proliferation And Survival In Pulmonary Hypertension
    Kudryashova, T. V.
    Goncharov, D. A.
    Pena, A.
    Kelly, N.
    Vanderpool, R. R.
    Baust, J. Jeff
    Kobir, A.
    Shufesky, W.
    Morelli, A. E.
    Zhao, J.
    Ihida-Stansbury, K.
    DeLisser, H.
    Tuder, R.
    Kawut, S. M.
    Sillje, H. H. W.
    Shapiro, S. D.
    Zhao, Y.
    Goncharova, E. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [24] Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension
    Cao, Y
    Li, H
    Mu, FT
    Ebisui, O
    Funder, JW
    Liu, JP
    FASEB JOURNAL, 2001, 15 (13): : 96 - +
  • [25] Estrogen receptor β mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation
    Watanabe, T
    Akishita, M
    Nakaoka, T
    Kozaki, K
    Miyahara, Y
    He, H
    Ohike, Y
    Ogita, T
    Inoue, S
    Muramatsu, M
    Yamashita, N
    Ouchi, Y
    CARDIOVASCULAR RESEARCH, 2003, 59 (03) : 734 - 744
  • [26] PROLIFERATION OF VASCULAR SMOOTH-MUSCLE IN EXPERIMENTAL HYPERTENSION
    BEVAN, RD
    CIRCULATION, 1974, 50 (04) : 31 - 31
  • [27] Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension
    Dai, Zhiyu
    Zhu, Maggie M.
    Peng, Yi
    Jin, Hua
    Machireddy, Narsa
    Qian, Zhijian
    Zhang, Xianming
    Zhao, You-Yang
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (06) : 788 - 802
  • [28] BDNF/TrkB Signaling Augments Smooth Muscle Cell Proliferation in Pulmonary Hypertension
    Kwapiszewska, Grazyna
    Chwalek, Karolina
    Marsh, Leigh M.
    Wygrecka, Malgorzata
    Wilhelm, Jochen
    Best, Johannes
    Egemnazarov, Bakytbek
    Weisel, Friederike C.
    Osswald, Sarah L.
    Schermuly, Ralph T.
    Olschewski, Andrea
    Seeger, Werner
    Weissmann, Norbert
    Eickelberg, Oliver
    Fink, Ludger
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (06): : 2018 - 2029
  • [29] FBLN7 mediates vascular smooth muscle cell phenotype switching and vascular remodeling in hypertension
    Yao, Guoqing
    Zheng, Xuehui
    Hu, Yang
    Zhao, Yuan
    Kong, Binghui
    Ti, Yun
    li Bu, Pei
    THERANOSTICS, 2024, 14 (19): : 7569 - 7588
  • [30] Is vascular smooth muscle cell proliferation beneficial?
    Weissberg, PL
    Clesham, GJ
    Bennett, MR
    LANCET, 1996, 347 (8997): : 305 - 307